T-cell epitope identification

US10627411B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10627411-B2
Application numberUS-201515128923-A
CountryUS
Kind codeB2
Filing dateMar 25, 2015
Priority dateMar 27, 2014
Publication dateApr 21, 2020
Grant dateApr 21, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is a method for determining the identity of the epitopes recognized by T-cells. The method consists of expressing an encoded library of candidate epitope sequences in a recipient reporter cell capable of providing a detectable signal upon cytotoxic attack from a single cognate T-cell followed by contacting the reporter cells with T-cells of interest. The reporter cells with a single indicating cytotoxic attack from a T-cell are isolated and then analyzed by next-generation sequencing in order to identify the epitope sequences. Specifically disclosed is a method in which a library of candidate epitope-encoding nucleic acids are expressed in cells which feature a membrane-bound major histocompatibility complex (MHC) protein, said library produced by transfection of plasmids featuring both a nucleotide encoding the candidate epitope and a nucleotide encoding a FRET-based fluorescent protein cleaved by granzyme.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for determining epitopes recognized by cytotoxic T-cells, the method comprising the steps of: expressing a library of candidate epitope-encoding nucleic acids in reporter cells capable of presenting expressed peptides of such candidate epitope-encoding nucleic acids in the context of a membrane-bound major histocompatibility complex (MHC) protein wherein the reporter cells are modified to carry a fluorescence-based signaling system in their cytosols that generates a fluorescent signal whenever a peptide linkage in the system is enzymatically cleaved by a granzyme A, B, H, K or M from granules of a cytotoxic T cell upon recognition of an expressed peptide in the context of an MHC protein on a reporter cell by such cytotoxic T cell; contacting in a reaction mixture a mixed population of the reporter cells expressing different candidate epitope-encoding nucleic acids of the library with a sample comprising cytotoxic T-cells, wherein effector functions of cytotoxic I-cells recognizing reporter cells are activated so that granzyme A, H, K or M in granules of the Cytotoxic T-cells are delivered by, a granzyme-perforin pathway to recognized reporter cells and cause a fluorescent signal to be venerated by the reporter cells; isolating intact reporter cells generating fluorescent signals; extracting candidate epitope-encoding nucleic acids from the isolated intact reporter cells; and sequencing the candidate epitope-encoding nucleic acids of the reporter cells to identify the epitope-encoding nucleic acids. 2. The method of claim 1 wherein said sample is from an individual and said MHC proteins of said reporter cells are matched with MHC proteins expressed by the individual. 3. The method of claim 2 wherein said reporter cells comprise autologous cells of said individual genetically modified to express candidate epitopes of said library. 4. The method of claim 3 wherein said autologous cells are B cells of said individual. 5. The method of claim 4 wherein said autologous cells are stably transfected or transformed by a vector capable of expressing said candidate epitopes of said library. 6. The method of claim 3 wherein said reporter cells are genetically modified to express a FRET-based fluorescent protein signaling system that generates a fluorescent signal whenever enzymatically cleaved by one of said granzyme A, B, H, K or M. 7. A method for determining epitopes recognized by cytotoxic T-cells, the method comprising the steps of: (a) expressing a library of candidate epitope-encoding nucleic acids or an enriched library of candidate epitope-encoding nucleic acids in reporter cells capable of presenting expressed peptides of such candidate epitope-encoding nucleic acids in the context of a membrane-bound major histocompatibility complex (MHC) protein wherein the reporter cells are modified to carry a fluorescence-based signaling system that generates a fluorescent signal whenever a peptide linkage in the system is enzymatically cleaved by a granzyme A, B, H, K or M from granules of a granzyme-perforin pathway of a cytotoxic T cell upon recognition of an expressed peptide in the context of an MHC protein on a reporter cell by such cytotoxic T cell; (b) contacting in a reaction mixture a mixed population of the reporter cells expressing different candidate epitope-encoding nucleic acids of the library with a sample comprising cytotoxic T-cells; (c) isolating reporter cells generating a fluorescent signal indicating recognition by a cytotoxic T-cell; (d) extracting candidate epitope-encoding nucleic acids from the isolated reporter cells and generating therefrom an enriched library of candidate epitope-encoding nucleic acids; (e) repeating steps (a)-(d) with the enriched library of candidate epitope-encoding nucleic acids until a frequency of reporter cells generating the signal indicating recognition by a cytotoxic T-cell is greater than or equal to a predetermined value; (f) sequencing the candidate epitope-encoding nucleic acids of reporter cells generating said signal to identify sequences of the epitope-encoding nucleic acids. 8. The method of claim 7 wherein said step of isolating includes sorting said reporter cells by a fluorescently activated cell sorter (FACS).

Assignees

Inventors

Classifications

  • Preparation or screening of expression libraries, e.g. reporter assays · CPC title

  • Expression markers · CPC title

  • in epitope analysis · CPC title

  • Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display · CPC title

  • Methods of identifying protein-protein interactions in protein mixtures · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10627411B2 cover?
The present invention is a method for determining the identity of the epitopes recognized by T-cells. The method consists of expressing an encoded library of candidate epitope sequences in a recipient reporter cell capable of providing a detectable signal upon cytotoxic attack from a single cognate T-cell followed by contacting the reporter cells with T-cells of interest. The reporter cells wit…
Who is the assignee on this patent?
British Columbia Cancer Agency, British Columbia Cancer Agency Branch
What technology area does this patent fall under?
Primary CPC classification G01N33/6878. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).